Lapsed Oct 23, 2026 on the fee record · Low confidence
20-year base term ends Apr 12, 2031
Second maintenance fee unpaid; grace period ended. The USPTO has not yet posted the lapse.
Filed Apr 12, 2011 as application 13/085,338 · Granted Oct 23, 2018
Base term, 20 years from filing, plus 120 days of patent term adjustment (USPTO delay)
Today
Lapsed Oct 23, 2026
2011
2031
Clock starts
Apr 12, 2011
Apr 12, 2011
No longer in force
Oct 23, 2026
Oct 23, 2026
Granted
Oct 23, 2018
Oct 23, 2018
Term would have run to
Aug 10, 2031
Aug 10, 2031
base term
patent term adjustment
after the term ends
fee events
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
120
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
Its term would have run to Aug 10, 2031: its 20-year base term plus 120 days of term adjustment for prosecution delay. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 12, 2011, when this application, 13/085,338, was filed | Apr 12, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +120 days, USPTO patent term adjustment record | Aug 10, 2031 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No fee event states this; the fee state is read from the payments the fee record holds; the fee record shows no payment for this window, and USPTO's status still reads "Patented Case" | lapsed Oct 23, 2026 | Low confidence |
| Computed term end | The steps above, in order | Oct 23, 2026 | Low confidence |
This family
| US 10,105,372 | this patent Oct 2026 | Oct 2026 |
| US 11,911,395 | In force Aug 2031 | Aug 2031 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 10, 2011 Reel 26427, frame 698 | Meyer, Colin J.; Huff, Warren | Reata Pharmaceuticals | Assignment of Assignor's Interest |
| Aug 23, 2012 Reel 28840, frame 735 | Meyer, Colin J.; Huff, J. Warren | Reata Pharmaceuticals, Inc. | Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 026427 Frame 0698. Assignor(S) Hereby Confirms the the Entire Right, Title, and Interest for the United States and All Foreign Countries in and to Any and All Improvements. |
| Jun 14, 2018 Reel 46357, frame 605 | Reata Pharmaceuticals, Inc. | Oxford Finance LLC, as Collateral Agent | Security Interest |
| Jun 24, 2020 Reel 53034, frame 18 | Oxford Finance LLC, as Collateral Agent | Reata Pharmaceuticals, Inc. | Release of Security Interest |
| Jan 4, 2022 Reel 58639, frame 138 | Reata Pharmaceuticals, Inc. | Reata Pharmaceuticals Holdings, LLC | Assignment of Assignor's Interest |
| May 18, 2023 Reel 63697, frame 461 | Reata Pharmaceuticals Holdings, LLC; Reata Pharmaceuticals Global, Inc.; Reata Pharmaceuticals, Inc. | Biopharma Credit PLC | Patent Security Agreement |
| Jul 12, 2023 Reel 64264, frame 557 | Reata Pharmaceuticals Holdings, LLC; Reata Pharmaceuticals Global, Inc.; Reata Pharmaceuticals, Inc. | Biopharma Credit PLC | Amended and Restated Patent Security Agreement |
| Apr 9, 2025 Reel 70793, frame 228 | Biopharma Credit PLC | Reata Pharmaceuticals Holdings, LLC; Reata Pharmaceuticals Global, Inc.; Reata Pharmaceuticals, Inc. | Release of Security Interest |
| Apr 9, 2025 reel/frame not recorded | Biopharma Credit PLC | Reata Pharmaceuticals Holdings, LLC | Release of Security Interest |
| Apr 9, 2025 reel/frame not recorded | Biopharma Credit PLC | Reata Pharmaceuticals Global, Inc. | Release of Security Interest |
| Apr 9, 2025 reel/frame not recorded | Biopharma Credit PLC | Reata Pharmaceuticals, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Note
The 120 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
70
later US patents cite this one
That is top 5% of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.